pharma · Chronic Kidney Disease Requiring Chronic Dialysis · UNCY
Unicycive Therapeutics
Unicycive Therapeutics is a pharma organization headquartered in Los Altos, USA. It trades on NYSE under ticker UNCY. Primary therapeutic focus areas include Chronic Kidney Disease Requiring Chronic Dialysis. NovaPharmaN
Los Altos, USA HQ
2016 Founded
23 Employees
Public company Type
UNCY · NYSE Ticker
Company details
- Status
- Public
- HQ
- Los Altos, USA
- Founded
- 2016
- Employees
- 23
- Programs
- 1
- Drugs
- 3
- Patents
- 4
Oxylanthanum Carbonate
Phase 2 · small molecule · Chronic Kidney Disease Requiring Chronic Dialysis
Oxylanthanum Carbonate for Chronic Kidney Disease Requiring Chronic Dialysis is a Phase 2 program (small_molecule) at Unicycive Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code UNI-OLC-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Unicycive Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Chronic Kidney Disease Requiring Chronic Dialysis
- Status
- completed
- Trials
- 1